Shoker Investment Counsel’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-2,140
Closed -$237K – 93
2022
Q1
$237K Hold
2,140
– – 0.12% 86
2021
Q4
$221K Hold
2,140
– – 0.1% 95
2021
Q3
$268K Hold
2,140
– – 0.13% 83
2021
Q2
$265K Hold
2,140
– – 0.13% 82
2021
Q1
$252K Hold
2,140
– – 0.13% 83
2020
Q4
$250K Hold
2,140
– – 0.14% 81
2020
Q3
$222K Buy
+2,140
New +$215K 0.15% 79
2020
Q1
– Sell
-2,140
Closed -$242K – 92
2019
Q4
$242K Hold
2,140
– – 0.16% 89
2019
Q3
$232K Hold
2,140
– – 0.17% 85
2019
Q2
$208K Buy
+2,140
New +$195K 0.15% 93
2018
Q4
– Sell
-2,050
Closed -$201K – 107
2018
Q3
$201K Buy
+2,050
New +$190K 0.15% 98

Other funds holding MDT

Shoker Investment Counsel's MDT Position: Q2 2022 in Review

Shoker Investment Counsel sold out of Medtronic (MDT) in Q2 2022, closing a stake of 2,140 shares — an estimated $237K sold.

Shoker Investment Counsel first reported a position in MDT in Q3 2018 and held it in 11 quarters. The position peaked at $268K in Q3 2021. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Shoker Investment Counsel reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Shoker Investment Counsel sold 2,140 Medtronic shares in Q2 2022, an estimated $237K.
  • Shoker Investment Counsel first reported a position in Medtronic in Q3 2018 and held it in 11 quarters.
  • Shoker Investment Counsel's Medtronic position peaked at $268K in Q3 2021.
  • 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Shoker Investment Counsel's 13F filing for Q2 2022, filed 9 Aug 2022.